India's First ever Cholesterol Goal Awareness Icon released Meghna A Singhania29 Sept 2020 4:20 PM ISTNew Delhi: Accentuating on one of the most neglected ailment that in reality is as fatal as Hypertension or Diabetes, pharma major Dr Reddy's...
Elevated LDL cholesterol during childhood linked to CVD risk later: JACC study Dr. Kamal Kant Kohli23 Sept 2020 10:30 AM ISTHigh cholesterol levels are never safe, not even in young people, and physicians should aim for optimal LDL-cholesterol levels early in adulthood if...
VA/DoD Dyslipidemia guidelines recommend against frequent LDL testing Dr. Kamal Kant Kohli22 Sept 2020 11:45 AM ISTU.S. Department of Veterans Affairs and Department of Defense has released new guidelines on management of dyslipidemia.The guideline is intended to...
Tafolecimab significantly reduces LDL-C, confirms Phase 1/2 Clinical Study Hina Zahid4 Sept 2020 9:45 AM ISTTafolecimab, an innovative PCSK9 inhibitor developed locally with good safety and tolerability profile, can significantly reduce LDL-C, find phase 1/2...
New analysis confirms LDL-C lowering effect of investigational inclisiran: ESC update Hina Zahid1 Sept 2020 11:56 AM ISTEAST HANOVER, N.J. - A post-hoc analysis of pooled data from the Phase III ORION-10 and -11 trials evaluatedthe individual responses of patients on...
Plant-based meats improve some CV risk factors compared with red meat: Study Hina Zahid13 Aug 2020 11:05 AM ISTResearchers at Stanford Medicine have found in a new study that swapping out red meat for certain plant-based meat alternatives can improve some...
lifestyle intervention in kids reduces LDL C and atherosclerosis risk Dr. Kamal Kant Kohli29 May 2020 7:49 PM ISTHigher plasma total and LDL cholesterol concentrations in childhood have been reported to be associated with atherosclerosis in adulthood.Researchers...
Statins may help reduce weight by altering gut microbiota Dr. Kamal Kant Kohli7 May 2020 12:45 PM ISTScientists while investigating a potential role of the gut microbiota in the development of cardio-metabolic diseases have identified common...
Alirocumab cuts LDL cholesterol by 35% in familial hypercholesterolemia Hina Zahid4 April 2020 9:00 PM ISTThe cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous...
Evinacumab cuts LDL cholesterol by half in familial hypercholesterolemia Dr. Kamal Kant Kohli3 April 2020 5:45 PM ISTMonoclonal antibody, Evinacumab effective for the full spectrum of homozygous familial hypercholesterolemia
Daily use of sugary drinks increases dyslipidemia risk Dr. Kamal Kant Kohli27 Feb 2020 9:15 AM ISTBOSTON -- People who consume sugary drinks every day were at greater risk of developing abnormal lipid levels.Researchers have found that middle-aged...
Controlling Cholesterol: FDA approves Nexletol- FIRST once daily, non-statin treatment for familial hypercholesterolemia Dr. Kamal Kant Kohli22 Feb 2020 12:47 PM ISTIt is the first oral, once-daily, Non-Statin LDL-Cholesterol lowering medicine approved in the U.S. in nearly 20 Years for indicated patients.
